Results 191 to 200 of about 790,262 (299)

Severity of maternal anemia and the risk of giving birth to a small vulnerable newborn: A cohort analysis of the WOMAN‐2 trial in four countries

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To investigate the association between maternal hemoglobin concentration and the risk of birth to a small vulnerable newborn (SVN). Methods We conducted a cohort analysis of women with moderate or severe anemia enrolled in the World Maternal Antifibrinolytic Trial‐2 (WOMAN‐2) across Nigeria, Pakistan, Tanzania, and Zambia (August ...
Henry Ochola   +114 more
wiley   +1 more source

Ileal tuberculosis presenting with severe unexplained anemia and unusual pseudo-tumoral imaging features: A case report. [PDF]

open access: yesRadiol Case Rep
Abourak C   +7 more
europepmc   +1 more source

Reported tuberculosis in the United States, 2007, 1996 [Tables]

open access: yes
Suggested citation: Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2007, 1996. July 1997 (inclusive page numbers)ustb96.pdfTable 1.

core  

Human biomarker navigator

open access: yesiMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

Monocyte inflammation and adaptive immune dysfunction in severe Klebsiella pneumoniae pneumonia

open access: yesiMeta, EarlyView.
Severe Klebsiella pneumoniae pneumonia combines intense inflammation with failure to control infection, yet the cellular basis is unclear. Using a severity‐focused single‐cell atlas of 708,894 peripheral blood mononuclear cells from 100 individuals, complemented by plasma protein measurements and flow cytometry, we show that disease severity redirects ...
Hongquan Chen   +23 more
wiley   +1 more source

Tofacitinib Regulates β‐Catenin Nuclear Translocation to Inhibit FLS Migration and Alleviate Clinical Symptoms of RA

open access: yesiNew Medicine, EarlyView.
ABSTRACT Objective Tofacitinib is a Janus kinase (JAK) inhibitor approved for the treatment of moderate‐to‐severe rheumatoid arthritis (RA). However, its synovium‐related molecular mechanisms, particularly its regulatory effect on fibroblast‐like synoviocyte (FLS) migration, remain incompletely understood.
Shuqi Fang   +13 more
wiley   +1 more source

One Health to Advance Tuberculosis Elimination in Brazil: A New Area of the Brazilian Tuberculosis Research Network. [PDF]

open access: yesRev Soc Bras Med Trop
Souza FN   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy